Evaluating vaccines for HIV using nonhuman primates
Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates
['FUNDING_OTHER'] · BIOQUAL, INC. · NIH-11060169
This study is looking at how well different HIV vaccines and prevention methods work using nonhuman primates, with the goal of finding effective ways to stop or control HIV infection.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BIOQUAL, INC. (nih funded) |
| Locations | 1 site (ROCKVILLE, UNITED STATES) |
| Trial ID | NIH-11060169 on ClinicalTrials.gov |
What this research studies
This research focuses on the use of nonhuman primates to evaluate potential HIV vaccines and prevention strategies. The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for researchers to conduct preclinical studies, allowing for thorough assessments of immune responses and vaccine efficacy. By utilizing these models, the research aims to identify effective vaccines that can prevent or control HIV infection. The program supports all stages of AIDS vaccine research, from initial evaluations to clinical testing.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at high risk for HIV who may eventually receive effective vaccines developed through these studies.
Not a fit: Patients who are already living with HIV or those who do not have access to vaccine programs may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection, significantly impacting public health.
How similar studies have performed: Previous research using nonhuman primates for vaccine evaluation has shown promising results, indicating that this approach is both established and effective.
Where this research is happening
ROCKVILLE, UNITED STATES
- BIOQUAL, INC. — ROCKVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEWIS, MARK — BIOQUAL, INC.
- Study coordinator: LEWIS, MARK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.